XML 89 R79.htm IDEA: XBRL DOCUMENT v3.23.4
Related Parties (Details narrative) - USD ($)
$ / shares in Units, $ in Millions
 9 Months Ended
Sep. 30, 2023
Mar. 21, 2023
Dec. 31, 2022
Common stock shares issued 7,008,002   2,161,950
Convertible Promissory Notes $ 25.1    
Convertible Notes 7,856,251    
Interest accrued $ 13.9    
Business Combination, Description Mr. Jenkins and his affiliates received 1,325.838 shares of Series X Convertible Preferred Stock in the merger, and Mr. Jenkins’ adult children received 1,284.344 shares of Series X Convertible Preferred Stock in the merger, all in exchange for their equity interests in Catheter in accordance with the merger exchange ratio    
Accrued expenses $ 1.4    
Mr. Jenkins [Member]      
Common stock shares issued   991,828,000  
Accrued expenses $ 1.1    
Options to purchase 144,169,000    
Number of options 140,816,000    
Remaining number of options 3,353,000    
Conversion of stock description conversion of 991.828 shares of Series X Convertible Preferred Stock, and 235,320 shares of common stock to his adult children upon conversion of 235.320 shares of Series X Convertible Preferred Stock    
Exercise price $ 0.59    
Remaining number of options exercise price $ 2.02